| Bioactivity | N6-Benzoyl-3’-O-(2-methoxyethyl)adenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | N6-Benzoyl-3’-O-(2-methoxyethyl)adenosine |
| CAS | 256223-99-1 |
| Formula | C20H23N5O6 |
| Molar Mass | 429.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
N6-Benzoyl-3’-O-(2-methoxyethyl)adenosine
CAS: 256223-99-1 F: C20H23N5O6 W: 429.43
N6-Benzoyl-3’-O-(2-methoxyethyl)adenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitum
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.